Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07565311

Two-week Intensive Outpatient Trauma Treatment.

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment.In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, men and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Posttraumatic Stress Disorder (PTSD) Mental Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment. In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, males and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PTSD
  • 18-65 years
  • Able to give written informed consent.

Exclusion criteria

  • Active substance abuse
  • psychotic or bipolar disorder
  • organic brain disorder
  • IQ< 70
  • Currently in a life-threating situation.
  • Serious suicide risk.

Treatment and study plan

Prolonged exposure and EMDR

Other

Two-week intensive traume treatment

Other names: EMDR, prolonged exposure

Primary outcomes

  1. Trauma symptom score as measured by International Trauma Questionnaire (ITQ)

    Time frame: 12 weeks

    ITQ: Higher score equals higher symptom load

Secondary outcomes

  1. Function as measured by Work and social adjustment scale (WSAS)

    Time frame: 12 weeeks

    Higher scores equals poorer function

Other outcomes

  1. Quality of life as measured by WHO-5, PTSD symptom load as measured by PCL-5

    Time frame: 12 weeks

    Higher scores on WHO-5 equals better QoL, Higher scores on PCL-5 equal more PTSD symptoms

Study contacts

Contact information is provided by the study sponsor or research team.

Julie H Evensen, MD PhD

CONTACT

[email protected]

004799339292

Veronica Vaage-Kowalzik, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 4, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.